Cargando…
CAR-T-Zell-basierte Immuntherapien in der Hämatoonkologie: Fokus auf den Einsatz in der klinischen Routine
Chimeric antigen receptor (CAR)-T-cell-based therapies are a modern pillar in immunotherapy. They show promising response rates in relapsed/refractory B and plasma cell malignancies. Cancer recurrence after initial response and lack of efficacy against solid tumors are key challenges for health care...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842198/ http://dx.doi.org/10.1007/s00761-022-01299-1 |